SURAKSHA
Suraksha Diagnostic Ltd.
Each stock's 10,000-path forecast, rendered as light.
Suraksha Diagnostic Ltd. (SURAKSHA) Stock Analysis & Case Study
Is SURAKSHA a good buy? The data-driven verdict.
Suraksha Diagnostic Ltd. (SURAKSHA) trades at ₹251,on the numbers it tread carefully, a Downstox Snapshot Score of 41/100.
On the numbers, Suraksha Diagnostic Ltd. (SURAKSHA) tread carefully, a Downstox Snapshot Score of 41/100, weighing expensive at 40.7× earnings, ROE of 14.1%, a 55% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
SURAKSHA fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How SURAKSHA ranks against the 2,373 companies in our screener
- SURAKSHA's market cap of 1,300 Cr ranks in the 44th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SURAKSHA's book value of ₹47 ranks in the 32nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SURAKSHA's promoter holding of 49.1% ranks in the 28th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SURAKSHA's 3-year profit (PAT) growth of 61.0% ranks in the 87th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SURAKSHA's 3-year revenue growth of 18.0% ranks in the 69th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SURAKSHA's debt-to-equity ratio of 0.53x is lower than 33% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is SURAKSHA overvalued? SURAKSHA P/E vs peers
SURAKSHA trades at 40.7× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
SURAKSHA share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 1.6y of SURAKSHA history (-31%/yr drift, 33%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| SURAKSHA 2027 | ₹169 | ₹260 | ₹399 | +4% |
| SURAKSHA 2028 | ₹149 | ₹271 | ₹493 | +8% |
| SURAKSHA 2029 | ₹135 | ₹282 | ₹590 | +13% |
| SURAKSHA 2030 | ₹125 | ₹294 | ₹687 | +18% |
| SURAKSHA 2031 | ₹118 | ₹306 | ₹794 | +23% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability SURAKSHA goes up, or doubles?
The bull case for SURAKSHA
- SURAKSHA's return on equity of 14.1% ranks in the 68th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹590.
The bear case & risks
- SURAKSHA's P/E of 40.4x is lower than 33% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹135.
SURAKSHA volatility & expected range, how bumpy is the ride?
Over the last 1.6 years SURAKSHA compounded at -31%/year with annualized volatility of 33%. That volatility implies a 1-year 80% range of ₹169-₹399, the honest backbone behind any single price target.
SURAKSHA price forecast, the full 60-month probability fan
SURAKSHA price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds SURAKSHA hits common targets within the simulated horizon?
Full multi-horizon detail on the SURAKSHA price target & forecast page.
SURAKSHA Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. SURAKSHA scores 6/8, mixed financial health.
SURAKSHA MTF margin & leverage across 5 brokers
Margin Trading Facility lets you buy SURAKSHA with part of the capital. Lower margin % = higher leverage. Rates compared across 5 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Zerodha | 50.00% | 2.0× |
| Dhan | 40.00% | 2.5× |
| Kotak Neo | 100.00% | 1.0× |
| Pocketful | 50.00% | 2.0× |
| Share IndiaCHEAPEST | 29.28% | 3.4× |
Compare every broker on the SURAKSHA MTF page.
About Suraksha Diagnostic Ltd.: sector, index & market-cap context
Suraksha Diagnostic Ltd. (SURAKSHA) is a small-cap NSE-listed company, with a market capitalisation of ₹1,311 Cr. See more stocks on our screener.
How the SURAKSHA Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Suraksha Diagnostic Ltd.'s public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
SURAKSHA analysis, FAQs
Is Suraksha Diagnostic Ltd. (SURAKSHA) a good buy?
On the numbers, Suraksha Diagnostic Ltd. (SURAKSHA) tread carefully, a Downstox Snapshot Score of 41/100, weighing expensive at 40.7× earnings, ROE of 14.1%, a 55% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is SURAKSHA overvalued or undervalued?
SURAKSHA trades at 40.7× earnings, expensive versus the ~22× long-run Nifty average.
What is the SURAKSHA share price target for 2031?
SURAKSHA's probability-weighted 2031 median target is ₹306, with an 80% range of ₹118-₹794 (10,000-path Monte-Carlo).
What is the probability SURAKSHA doubles in 5 years?
The modelled probability of SURAKSHA reaching ₹499 (2×) within 5 years is 25%.
What is the bull case for SURAKSHA?
SURAKSHA's return on equity of 14.1% ranks in the 68th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in SURAKSHA?
SURAKSHA's P/E of 40.4x is lower than 33% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.